Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Camurus Community
OM:CAMX Community
1
Narratives
written by author
0
Comments
on narratives written by author
29
Fair Values set
on narratives written by author
Create a narrative
Camurus
Popular
Undervalued
Overvalued
Community Investing Ideas
Camurus
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
Establishing US Operations And Launching Oclaiz Will Drive Future Success
Key Takeaways Strategic U.S. commercial expansion and new product launches could significantly boost revenue and market penetration. Robust R&D pipeline and geographic expansion aim to enhance future revenue and net margins through successful product approvals and manufacturing efficiencies.
View narrative
SEK 758.50
FV
22.2% undervalued
intrinsic discount
43.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
21
users have followed this narrative
6 days ago
author updated this narrative
Your Valuation for
CAMX
CAMX
Camurus
Your Fair Value
SEK
Current Price
SEK 590.00
44.3% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-290m
6b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 5.9b
Earnings SEK 1.4b
Advanced
Set Fair Value